Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ: 011040)

Kyung Dong Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	21,994	11,779	14,553	17,807	15,992	62,953
Short-Term Investments	-	165.11	445.08	12,000	32,445	13,150
Trading Asset Securities	16,620	20,130	30,130	20,236	12,911	18,255
Cash & Short-Term Investments	38,614	32,075	45,128	50,043	61,348	94,358
Cash Growth	-1.45%	-28.93%	-9.82%	-18.43%	-34.98%	12.44%
Accounts Receivable	17,369	19,156	24,878	21,084	17,581	19,780
Other Receivables	1,573	1,416	591.23	423.74	764.38	460.76
Receivables	18,942	20,572	25,469	21,508	18,643	20,241
Inventory	43,906	34,535	30,158	29,770	28,926	25,105
Prepaid Expenses	1,508	1,141	831.9	865.31	61.61	765.92
Other Current Assets	1,030	1,427	1,394	1,022	776.29	1,842
Total Current Assets	104,001	89,749	102,981	103,208	109,755	142,312
Property, Plant & Equipment	75,184	73,646	95,097	89,880	88,585	66,513
Long-Term Investments	70,731	73,947	77,107	68,066	62,646	50,326
Other Intangible Assets	5,594	5,689	2,889	2,998	2,194	2,460
Long-Term Deferred Tax Assets	2,070	1,557	-	-	-	-
Other Long-Term Assets	46,757	48,083	32,403	27,822	28,214	25,978
Total Assets	304,637	292,971	310,478	291,974	291,394	287,589
Accounts Payable	5,779	4,880	5,657	5,751	3,878	6,141
Accrued Expenses	7,054	6,801	1,463	1,496	1,468	1,370
Short-Term Debt	53,850	15,015	24,085	153.95	635.87	18.07
Current Portion of Leases	123.93	276.64	1,350	1,489	706.64	1,362
Current Income Taxes Payable	-	4,743	1,877	2,770	4,742	4,544
Current Unearned Revenue	-	-	1.76	-	-	-
Other Current Liabilities	15,430	27,310	15,693	13,705	14,568	9,712
Total Current Liabilities	82,237	59,027	50,127	25,364	25,999	23,148
Long-Term Debt	-	-	-	-	-	25,199
Long-Term Leases	17.19	81.08	1,434	2,686	420.56	717.18
Long-Term Deferred Tax Liabilities	-	-	1,045	1,016	826.57	1,267
Other Long-Term Liabilities	3,952	5,386	347.25	2,618	1,386	2,391
Total Liabilities	86,206	64,494	52,953	31,684	28,632	52,722
Common Stock	15,684	15,684	15,684	15,684	15,684	13,575
Additional Paid-In Capital	34,100	34,108	34,108	34,219	34,198	10,228
Retained Earnings	190,571	198,616	231,800	228,447	227,040	221,138
Treasury Stock	-30,133	-28,916	-28,916	-28,166	-22,890	-21,535
Comprehensive Income & Other	7,921	8,686	4,528	9,637	8,155	3,300
Total Common Equity	218,144	228,179	257,204	259,821	262,187	226,706
Minority Interest	287.01	298.06	320.83	468.74	575.04	8,161
Shareholders' Equity	218,431	228,477	257,525	260,290	262,762	234,867
Total Liabilities & Equity	304,637	292,971	310,478	291,974	291,394	287,589
Total Debt	53,992	15,373	26,869	4,329	1,763	27,296
Net Cash (Debt)	-15,377	16,701	18,259	45,714	59,585	67,062
Net Cash Growth	-	-8.53%	-60.06%	-23.28%	-11.15%	-19.09%
Net Cash Per Share	-566.35	615.52	671.07	1660.97	2428.55	2832.22
Filing Date Shares Outstanding	26.94	27.13	27.13	27.23	27.71	23.68
Total Common Shares Outstanding	26.94	27.13	27.13	27.23	27.71	23.68
Working Capital	21,764	30,722	52,854	77,844	83,756	119,164
Book Value Per Share	8096.88	8409.41	9479.11	9540.40	9461.29	9574.44
Tangible Book Value	212,551	222,490	254,315	256,823	259,993	224,246
Tangible Book Value Per Share	7889.26	8199.75	9372.64	9430.31	9382.13	9470.55
Land	17,847	17,847	26,002	17,372	17,372	16,276
Buildings	70,227	67,935	78,165	58,125	58,124	56,681
Machinery	62,822	60,966	60,360	66,259	65,063	60,373
Construction In Progress	4,233	4,438	2,565	21,513	21,473	1,458

Source: S&P Capital IQ. Standard template. Financial Sources.